Trevi Therapeutics (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.
Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.
ServiceTitan (TTAN) stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.
Over 2.94 million shares of the company traded intraday.
Liquidity Services (LQDT) shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.
Almost 956,000 shares traded intraday compared with a daily average of about 117,000.
Price: 4.33, Change: +1.84, Percent Change: +73.86
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。